Klotho Neurosciences registers up to 75.1M shares for resale by selling stockholders; company receives no proceeds

Filed February 24, 2026 · ~1 min read

Key Changes

• high

  The prospectus registers up to 75,103,879 shares for resale by selling stockholders, including 34,551,939 shares and warrants from a pending private placement.

  The Offering verify on EDGAR →
• high

  The company will not receive any proceeds from the sale of shares by selling stockholders; all proceeds go to those selling shareholders.

  The Offering verify on EDGAR →
• medium

  The registration includes 3,500,000 shares currently held by selling stockholders and 2,500,000 shares issuable upon exercise of existing warrants.

  The Offering verify on EDGAR →